Table 1 Patient characteristics
Age (mean) at the time of fgEA in years | 43.81± 5. 1 |
Parity (mean) at the time of fgEA | 2.12 ± 0.98 |
History of cesarean section at the time of fgEA | 41 (19 %) |
Preoperative bleeding pattern | |
Menorrhagia | 202 (93 %) |
Metrorrhagia | 16 (7 %) |
Dysmenorrhea associated with the problem of PDB | 39 (18 %) |
Duration of blood loss before the fgEA in months | |
>12 | 160 (73 %) |
6–12 | 45 (21 %) |
<6 | 13 (6 %) |
Therapy before the fgEA | 119 (55 %) |
Hormonal medication | 85 (39 %) |
Tranexamic acid | 17 (8 %) |
NSAID | 7 (3 %) |
LNGIUS | 35 (16 %) |
Dilation/curettage | 20 (9 %) |
Subdermal contraceptive implant | 2 (1 %) |
Another hysteroscopic ablation | 1 (<1 %) |
Therapy after the fgEA | 36 (17 %) |
Hormonal medication | 9 (4 %) |
Tranexamic acid | 2 (1 %) |
NSAID | 0 (0 %) |
LNGIUS | 4 (2 %) |
Hysterectomy | 22 (10 %) |
Dilation/curettage | 2 (1 %) |
Another hysteroscopic ablation | 1 (<1 %) |
Subdermal contraceptive implant | 1 (<1 %) |
Interval (mean) between previous therapy and the fhEA in years | 2.94 ± 3.75 |
Interval (mean) between the fhEA therapy after in years | 1.38 ± 1.42 |